BioStem Technologies to Host First Quarter 2026 Financial Results Conference Call on May 14, 2026

Rhea-AI Summary

BioStem Technologies (OTC: BSEM) will release first quarter 2026 financial results on Thursday, May 14, 2026 and will host a conference call and webcast at 4:30 PM ET.

The webcast will include an overview of the quarter from management. Registration and live access details are provided via a webcast link and conference call numbers.

Conference call and webcast to be held at 4:30 PM ET

POMPANO BEACH, Fla., April 30, 2026 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (OTC: BSEM), a leading regenerative medicine company focused on the development, manufacturing, and commercialization of perinatal tissue allograft products, today announces it will release its first quarter 2026 financial results on Thursday, May 14, 2026, and will host a conference call and webcast at 4:30 PM ET.

The webcast will feature an overview of the quarter from BioStem Technologies management. To register for the event, please click HERE.

Conference Call & Webcast Information:

• Conference ID: 9695874
• North America Toll-Free: (800) 715-9871
• International Toll: +1 (646) 307-1963
• Webcast Link: https://events.q4inc.com/attendee/844730655

About BioStem Technologies, Inc. (OTC: BSEM): BioStem Technologies is a publicly traded, biomedical innovator, focused on developing, manufacturing and commercializing advanced allograft solutions derived from perinatal tissue. The company leverages its industry-leading proprietary BioRetain^®, CryoTek^® and SteriTek^® processing technologies, designed to optimize the preservation of the natural properties of these tissues, supporting their use in clinical settings. Its allografts are used by clinicians across a wide range of specialties. With a growing portfolio of products, expanding clinical research initiatives, and a national commercial footprint, BioStem is committed to advancing innovation in regenerative medicine.

BioStem Technologies’ quality management system and standard operating procedures have been reviewed and accredited by the American Association of Tissue Banks (“AATB”). These systems and procedures are established in compliance with current Good Tissue Practices (“cGTP”) and current Good Manufacturing Processes (“cGMP”). BioStem’s portfolio of quality brands includes its Neox^®, Clarix^®, VENDAJE^® and American Amnion™ product lines.

Join BioStem’s Distribution List & Social Media:
To follow the latest developments at BioStem, sign up for the Company’s email distribution list HERE, and follow us on X and LinkedIn.

Contact BioStem:
Website: www.biostemtechnologies.com
E-Mail: info@biostemtech.com
X: @BSEM_Tech
Facebook: BioStemTechnologies
Phone: 954-380-8342

Investor Relations:
Philip Trip Taylor, Gilmartin
Group E-Mail: ir@biostemtech.com

Public Relations:
Jennifer Horton, Relevance
jennifer@relevance.com

FAQ

When will BioStem Technologies (BSEM) release Q1 2026 results and host the conference call?

BioStem will release Q1 2026 results and host a conference call on May 14, 2026 at 4:30 PM ET. According to the company, management will provide an overview of the quarter during the webcast and take questions as time permits.

How can investors join the BioStem (BSEM) Q1 2026 webcast and conference call?

Investors can join via the provided webcast link or by dialing the conference numbers with Conference ID 9695874. According to the company, registration is available through the event page to obtain webcast access and caller instructions.

What conference call numbers and Conference ID will BioStem (BSEM) use for the May 14, 2026 event?

BioStem will use Conference ID 9695874 with North America toll-free (800) 715-9871 and international toll +1 (646) 307-1963. According to the company, those numbers provide live audio access to the call.

Where is the BioStem (BSEM) webcast link for the May 14, 2026 Q1 call?

The live webcast is available via the company’s event page at https://events.q4inc.com/attendee/844730655. According to the company, registered attendees can access the webcast through that link at the scheduled 4:30 PM ET start time.

Will BioStem (BSEM) provide a replay or transcript of the May 14, 2026 conference call?

The announcement does not state replay or transcript details; attendees should register to receive updates. According to the company, registration and the event page are the primary channels for post-event materials and any replay information.